Larson Financial Group’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83K Sell
49
-92
-65% -$2.82K ﹤0.01% 3150
2026
Q1
$4.7K Buy
141
+101
+253% +$3.39K ﹤0.01% 2639
2025
Q4
$1.38K Buy
40
+4
+11% +$128 ﹤0.01% 2860
2025
Q3
$980 Buy
36
+22
+157% +$532 ﹤0.01% 2929
2025
Q2
$294 Buy
+14
New +$269 ﹤0.01% 2981
2025
Q1
Sell
-29
Closed -$745 3137
2024
Q4
$745 Buy
+29
New +$821 ﹤0.01% 2106

Other funds holding IDYA

Larson Financial Group's IDYA Position: Q2 2026 in Review

Larson Financial Group reduced its IDEAYA Biosciences (IDYA) stake by 65% in Q2 2026, selling an estimated $2.82K and leaving 49 shares worth $1.83K. The position accounts for ﹤0.01% of the portfolio, ranked #3150.

Larson Financial Group first reported a position in IDYA in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.7K in Q1 2026. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Larson Financial Group held 49 shares of IDEAYA Biosciences worth $1.83K as of Q2 2026.
  • Larson Financial Group sold 92 IDEAYA Biosciences shares in Q2 2026, an estimated $2.82K.
  • IDEAYA Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3150 holding.
  • Larson Financial Group first reported a position in IDEAYA Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Larson Financial Group's IDEAYA Biosciences position peaked at $4.7K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.